Log In
person
Sorrento Therapeutics Inc
SRNE
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2022
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Scilex |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
38.03M | 60.53% |
| Sorrento Therapeautics |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
24.81M | 39.47% |
| keyboard_arrow_down |
Scilex
Branded Pharmaceuticals
|
38.03M | 60.53% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Sorrento Therapeautics
Pre-Revenue Pharmaceuticals
|
24.81M | 39.47% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||